S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
NYSEAMERICAN:NNVC

NanoViricides - NNVC Stock Forecast, Price & News

$1.20
-0.04 (-3.23%)
(As of 03/28/2023 04:33 PM ET)
Add
Compare
Today's Range
$1.20
$1.29
50-Day Range
N/A
52-Week Range
$1.04
$3.88
Volume
18,268 shs
Average Volume
22,976 shs
Market Capitalization
$13.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.25

NanoViricides MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
337.5% Upside
$5.25 Price Target
Short Interest
Bearish
1.65% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.65 out of 5 stars


NNVC stock logo

About NanoViricides (NYSEAMERICAN:NNVC) Stock

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Receive NNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter.

NNVC Stock News Headlines

Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
NanoViricides Inc
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
See More Headlines
Receive NNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter.

NNVC Company Calendar

Last Earnings
2/14/2023
Today
3/28/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:NNVC
Previous Symbol
NYSEMKT:NNVC
Employees
17
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.25
High Stock Price Forecast
$5.25
Low Stock Price Forecast
$5.25
Forecasted Upside/Downside
+318.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-8,110,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.00 per share

Miscellaneous

Free Float
11,099,000
Market Cap
$14.58 million
Optionable
Optionable
Beta
0.93

Key Executives

  • Anil R. Diwan
    Executive Chairman, President & CEO
  • Meeta R. Vyas
    Chief Financial & Accounting Officer
  • Randall W. Barton
    Chief Scientific Officer
  • Jayant Tatake
    Vice President-Research & Development













NNVC Stock - Frequently Asked Questions

Should I buy or sell NanoViricides stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoViricides in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NNVC shares.
View NNVC analyst ratings
or view top-rated stocks.

What is NanoViricides' stock price forecast for 2023?

1 Wall Street research analysts have issued 12 month target prices for NanoViricides' stock. Their NNVC share price forecasts range from $5.25 to $5.25. On average, they predict the company's share price to reach $5.25 in the next year. This suggests a possible upside of 318.0% from the stock's current price.
View analysts price targets for NNVC
or view top-rated stocks among Wall Street analysts.

Are investors shorting NanoViricides?

NanoViricides saw a increase in short interest in March. As of March 15th, there was short interest totaling 183,800 shares, an increase of 103.5% from the February 28th total of 90,300 shares. Based on an average daily volume of 28,500 shares, the days-to-cover ratio is currently 6.4 days. Approximately 1.7% of the company's shares are sold short.
View NanoViricides' Short Interest
.

How were NanoViricides' earnings last quarter?

NanoViricides, Inc. (NYSEAMERICAN:NNVC) announced its quarterly earnings results on Tuesday, February, 14th. The company reported ($0.15) EPS for the quarter.

When did NanoViricides' stock split?

NanoViricides's stock reverse split on Tuesday, September 24th 2019. The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 23rd 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of NanoViricides own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoViricides investors own include Cytosorbents (CTSO), Rekor Systems (REKR), Inovio Pharmaceuticals (INO), Micron Technology (MU), Gilead Sciences (GILD), Novavax (NVAX), Sorrento Therapeutics (SRNE), Vaxart (VXRT), iBio (IBIO) and Moderna (MRNA).

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NNVC."

Who are NanoViricides' major shareholders?

NanoViricides' stock is owned by many different institutional and retail investors. Top institutional shareholders include Millennium Management LLC (0.58%), Susquehanna International Group LLP (0.00%), Simplex Trading LLC (0.00%), Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of NanoViricides?

Shares of NNVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoViricides' stock price today?

One share of NNVC stock can currently be purchased for approximately $1.26.

How much money does NanoViricides make?

NanoViricides (NYSEAMERICAN:NNVC) has a market capitalization of $14.58 million. The company earns $-8,110,000.00 in net income (profit) each year or ($0.62) on an earnings per share basis.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Dr, SHELTON, CT 06484-6153, United States. The official website for the company is www.nanoviricides.com. The company can be reached via phone at (203) 937-6137, via email at info@nanoviricides.com, or via fax at 203-859-5095.

This page (NYSEAMERICAN:NNVC) was last updated on 3/28/2023 by MarketBeat.com Staff